| Animal Models |
| |
Evaluate exposure routes to pathogens that require specialized containment safeguards |
| |
|
- Aerosol inhalation |
| |
|
- Arthropod-borne transmission |
| |
|
- Direct inoculation (s.c., i.m., i.v., i.t.) |
| |
Species diversity |
| |
|
- Mice, rats, hamsters, raccoons, dogs, cats, horses, cattle, aligators, and birds |
| |
|
(sparrows to emus) |
| |
|
|
| Genomics and Proteomics |
| |
Customized spotted DNA microarrays |
| |
|
- Mouse, Bukholderia, F. tularensis SCHU14 |
| |
Affymetrix gene chips |
| |
Proteome and protein identification via mass spectrometry and Biacore |
| |
Bioinformatics |
| |
Outsourcing support for standard services |
| |
|
- DNA sequencing, custom peptides, etc. |
| |
|
|
| Product Development and Manufacturing |
| |
GLP and cGMP production of reagents |
| |
Full or collaborative Development and Manufacturing service |
| |
Pre-IND Regulatory Guidance |
| |
BSL-2 and BSL-3 containment manufacturing of biologics in 3900 sq ft space |
| |
|
- CDC Category A-C Select Agents |
| |
Product hold, inventory, and long-term storage |
| |
|
- cGMP-compliant vaporized LN2 |
| |
|
|
| Biodefense Training |
| |
Train-the-Trainer programs |
| |
|
- Zoonotic diseases, general |
| |
|
- Avian flu |
| |
|
- Bovine spongiform encephalopathy (BSE) |